iRhythm Technologies Inc is thriving in the healthcare industry with a series of strategic partnerships, regulatory milestones, and innovative products that are set to redefine cardiac rhythm monitoring.

iRhythm Technologies Inc. reports a 20% increase in revenue for Q1 2025, driven by the success of its Zio long-term continuous monitoring service, which is expanding globally and boosting analyst optimism.

iRhythm Technologies Inc’s stock surged after Q1 2025 results showed a 20% jump in revenue, driven by strong demand for its cardiac rhythm monitoring devices and strategic expansion into Japan.

iRhythm Technologies has expanded into Japan with its AI-powered Zio ECG Monitoring Service, offering a superior monitoring duration and advanced arrhythmia detection capabilities to meet the growing demand in the Japanese market.